US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

231.24

+1.840.80%

Volume:4K

Turnover:914.90K

Market Cap:463.97M

PE:- -

High:232.09

Open:229.59

Low:229.59

Close:229.39

52wk High:244.35

52wk Low:160.91

Shares:2.01M

Float Shares:2.01M

Volume Ratio:0.47

T/O Rate:0.20%

Dividend:0.96

Dividend Rate:0.42%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Revolution Medicines Prices Metastatic Pancreatic Cancer Drug Rasonque at $39,800 a Month

MT Newswires Live

Revolution Medicines to Charge $39,800 a Month for Pancreatic Cancer Drug, Bloomberg Reports

MT Newswires Live

Revolution Medicines - Rasonque is NOW Commercially Available in the U.S. at a Wholesale Acquisition Cost of $39,800 for a 30-Day Supply - Conf Call

THOMSON REUTERS

Revolution Medicines Posts Investor Presentation on Rasonque FDA Approval

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

Revolution Medicines, - Rasonque 300 Mg Once-Daily Oral Tablets NOW Available in the U.S.

THOMSON REUTERS

U.S. FDA Approves Revolution Medicines’ Rasonque™ (Daraxonrasib), the First Broad Ras-Targeted Medicine in Metastatic Pancreatic Cancer

THOMSON REUTERS

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

FDA Approves Drug for Pancreatic Cancer in Incredible Moment for Deadly Disease

US FDA Approves Revolution Medicines' Pancreatic Cancer Drug

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

THOMSON REUTERS

Revolution Medicines CEO Mark A. Goldsmith Reports Disposal of Common Shares Worth $16.87 Million

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Political and General News Events from August 25

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/BBH/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":231.235,"timestamp":1789412915177,"preClose":229.3922,"halted":0,"volume":3962,"delay":0,"changeRate":0.008033403053809202,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Trading","change":1.8428,"latestTime":"09-14 15:14:05 EDT","open":229.5938,"high":232.085,"low":229.5938,"amount":914903.8514,"amplitude":0.01086,"askPrice":231.39,"askSize":100,"bidPrice":231.18,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":229.3922,"sharesOutstanding":1976503,"nav":229.3061,"aum":460103384.52,"dividendRate":0.004166,"bidAskSpread":0.001038,"postHourTrading":{"tag":"盘后","latestPrice":230.31,"preClose":229.3922,"latestTime":"19:30 EDT","volume":19,"amount":4352.4732,"timestamp":1789169405851,"change":0.9178,"changeRate":0.004001,"amplitude":0},"volumeRatio":0.471928,"impliedVol":0.1868,"impliedVolPercentile":0.3705},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.471928,"shares":2006503,"dividePrice":0.9634,"high":232.085,"amplitude":0.01086,"preClose":229.3922,"low":229.5938,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":231.235,"committee":0.5,"eps":0,"divideRate":0.004166,"volume":3962,"delay":0,"ttmEps":0,"open":229.5938,"prevYearClose":189.2649,"prevWeekClose":229.3922,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":241.1222,"twentyDayClose":218.0411,"sixtyDayClose":188.0998},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662749358","title":"Revolution Medicines Prices Metastatic Pancreatic Cancer Drug Rasonque at $39,800 a Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749358","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662749358?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:20","pubTimestamp":1787768430,"startTime":"0","endTime":"0","summary":"Revolution Medicines'  once-daily oral Rasonque tablets for the treatment of metastatic pancreatic cancer are available in the US at a price of $39,800 for a 30-day supply, the company said Wednesday in a regulatory filing.The US Food and Drug Administration approved Rasonque for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.Price: 215.95, Change: +4.57, Percent Change: +2.16","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTH","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BBH","IE0009354923.USD","IE00B2B36J28.USD","IE0002141913.USD","BK4139","IE0009355771.USD","CANC","IDNA","LU0320765992.SGD","LU0109394709.USD","RVMD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746776","title":"Revolution Medicines to Charge $39,800 a Month for Pancreatic Cancer Drug, Bloomberg Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746776","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662746776?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:02","pubTimestamp":1787767375,"startTime":"0","endTime":"0","summary":"Price: 215.72, Change: +4.34, Percent Change: +2.05","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJT1NW94.SGD","CANC","LU0320765992.SGD","RVMD","IE0009354923.USD","LU0109394709.USD","BK4139","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IDNA","LU0889565916.HKD","PTH","IE0009355771.USD","BBH","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662462057","title":"Revolution Medicines - Rasonque is NOW Commercially Available in the U.S. at a Wholesale Acquisition Cost of $39,800 for a 30-Day Supply - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2662462057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662462057?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:56","pubTimestamp":1787766961,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0O4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","BK4139","IDNA","IE00B4R5TH58.HKD","IE0009354923.USD","LU0889565916.HKD","RVMD","IE0002141913.USD","IE00BJT1NW94.SGD","BBH","PTH","IE00BFTCPJ56.SGD","CANC","IE00B2B36J28.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746411","title":"Revolution Medicines Posts Investor Presentation on Rasonque FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746411","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662746411?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766356,"startTime":"0","endTime":"0","summary":"Revolution Medicines posts investor presentation on RASONQUE FDA approvalRevolution Medicines released an investor presentation covering U.S. FDA approval of RASONQUE (daraxonrasib) for metastatic pan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL4qMXCX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","BK4139","IE00BJJMRZ35.SGD","CANC","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0002141913.USD","IE0009355771.USD","IDNA","IE00BJT1NW94.SGD","PTH","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","IE0009354923.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","LU0889565916.HKD","GDOC","MRNY","SYNB","PTH","IE00BFTCPJ56.SGD","LABU","LU0320765992.SGD","NVIB","PINK","BMED","TECB","BBH","XLVX","IEIH","TBXU","CANC","IE0002141913.USD","IYH","MEDI","IE00B4R5TH58.HKD","BBP","IBB","PSCH","LFSC","LU0109394709.USD","BK4139","IE0009355771.USD","BK4585","BK4588","FRTY","RVMD","IE00B2B36J28.USD","IDNA","IE00BJJMRZ35.SGD","GNMX","MRNX","IE00BJT1NW94.SGD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","IE0009354923.USD","IE00BJJMRZ35.SGD","TBXU","BBH","NVIB","PSCH","MRNX","BBP","TECB","BMED","BK4588","CANC","GNMX","RVMD","LABU","IBB","SYNB","LU0320765992.SGD","IE00B2B36J28.USD","BK4139","LU0109394709.USD","IE0002141913.USD","MRNY","RSPH","XLVX","IDNA","LU0889565916.HKD","BK4585","FRTY","PINK","GDOC","MEDI","IE00B4R5TH58.HKD","IE0009355771.USD","IYH","PTH","IE00BJT1NW94.SGD","IEIH","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745207","title":"Revolution Medicines, - Rasonque 300 Mg Once-Daily Oral Tablets NOW Available in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745207?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:59","pubTimestamp":1787763576,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUA6XRCYX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","IDNA","BBH","CANC","IE00BJT1NW94.SGD","LU0320765992.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4139","IE0002141913.USD","PTH","RVMD","IE00BFTCPJ56.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662452007","title":"U.S. FDA Approves Revolution Medicines’ Rasonque™ (Daraxonrasib), the First Broad Ras-Targeted Medicine in Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662452007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662452007?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:59","pubTimestamp":1787763576,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUA6XRCYX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0002141913.USD","CANC","BK4139","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IDNA","IE0009354923.USD","LU0320765992.SGD","LU0889565916.HKD","RVMD","PTH","IE00BJJMRZ35.SGD","LU0109394709.USD","BBH","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759746","title":"U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759746","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662759746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:59","pubTimestamp":1787763540,"startTime":"0","endTime":"0","summary":"RASONQUE is indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent syste","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351615/0/en/u-s-fda-approves-revolution-medicines-rasonque-daraxonrasib-the-first-broad-ras-targeted-medicine-in-metastatic-pancreatic-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124384867.USD","LU1861220033.SGD","LU1978683503.SGD","ONG","LU0109394709.USD","LU1720051017.SGD","LU0210528500.USD","ITT","IE0009354923.USD","LU1720051108.HKD","IE00BD6J9T35.USD","BK4023","IE00B4R5TH58.HKD","BK4588","IE00B2B36J28.USD","LU0724618433.USD","LU0053671581.USD","LU0889565916.HKD","LU0320765992.SGD","SRET","BK4009","LABU","TTDU","BK4605","L","LU2487616109.SGD","BK4585","IE0009355771.USD","ON","IE0002141913.USD","HR","BBH","LU1854103824.USD","TTD","CANC","PFS","PTH","BK4512","EMA","BK4141","LU1861219969.SGD","BK4613","RVMD","ONX","IE00BJJMRZ35.SGD","IDNA","BK4225","LU2360107325.USD","BK4139","IE00BZ199S13.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748785","title":"FDA Approves Drug for Pancreatic Cancer in Incredible Moment for Deadly Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748785?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:18","pubTimestamp":1787757480,"startTime":"0","endTime":"0","summary":"For four decades, cancer researchers fought to disable a stubborn mutation that made pancreatic cancer a death sentence-to little avail.Now, doctors have a medicine that targets the mutation. The Food","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","PTH","LU0320765992.SGD","RVMD","BK4588","CANC","BK4585","IE0002141913.USD","RDR.SI","IE00B4R5TH58.HKD","IE0009354923.USD","IDNA","IE00B2B36J28.USD","LU0109394709.USD","BK4139","LU0889565916.HKD","BBH","IE00BFTCPJ56.SGD","BK6027","BK6515","IE0009355771.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662107077","title":"US FDA Approves Revolution Medicines' Pancreatic Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2662107077","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662107077?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:43","pubTimestamp":1787755405,"startTime":"0","endTime":"0","summary":"US FDA approves Revolution Medicines' pancreatic cancer drugAug 26 (Reuters)-The U.S. Food and Drug Administration approved Revolution Medicines'RVMD.Otargeted drug for metastatic pancreatic cancer, the regulator said on Wednesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4N44N16Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0889565916.HKD","IE0009355771.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","CANC","RVMD","BBH","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4139","IE0009354923.USD","IE00BJJMRZ35.SGD","PTH","IE00BJT1NW94.SGD","LU0109394709.USD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662102887","title":"FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662102887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662102887?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:38","pubTimestamp":1787755107,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","IDNA","IE0009354923.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4139","IE0002141913.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0320765992.SGD","RVMD","LU0889565916.HKD","CANC","PTH","BBH","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662502718","title":"Revolution Medicines CEO Mark A. Goldsmith Reports Disposal of Common Shares Worth $16.87 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662502718","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662502718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:52","pubTimestamp":1787741522,"startTime":"0","endTime":"0","summary":"Revolution Medicines CEO Mark A. Goldsmith reports disposal of common shares worth $16.87 millionRevolution Medicines CEO Mark A. Goldsmith exercised stock options for 80,000 shares at USD 4.73 on Aug","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL5Nrx4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines CEO Mark A. Goldsmith Reports Disposal of Common Shares Worth $16.87 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","BK4139","IE00BJJMRZ35.SGD","CANC","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0002141913.USD","IE0009355771.USD","IDNA","IE00BJT1NW94.SGD","PTH","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","IE0009354923.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796495","title":"Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796495","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796495?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:32","pubTimestamp":1787733120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 2.1% to 5.74 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 37% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.2% and Amgen Inc. remained unchanged.Trading volume totaled 180.5 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU0889565916.HKD","IE00BJT1NW94.SGD","SG9999001440.SGD","AMGN","TBXU","BK1191","BK1521","IE0009355771.USD","IE00BZ08YS42.EUR","BK4533","BK4581","LU0320765992.SGD","IE00BJJMRZ35.SGD","BK4566","LU0868494617.USD","BK4139","BK1515","LU1023059063.AUD","IE00BFTCPJ56.SGD","BK4534","IE00B4R5TH58.HKD","BBH","IE00BZ08YT58.USD","IBB","LU0058720904.USD","IE00B2B36J28.USD","LU2242652126.USD","PJP","01177","LU2112291526.USD","LU2242646821.SGD","PBE","LU0109394709.USD","LU2089984988.USD","HK0000165453.HKD","IE00BZ08YR35.GBP","LU2468319806.SGD","LU0122379950.USD","LU1983299246.USD","LU1571399168.USD","BK4585","LU1057294990.SGD","BK1589","IE0002141913.USD","BK4599","BK4588","LU0289739699.SGD","BIB","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175230","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175230?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:35","pubTimestamp":1787690100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rose 1.38% to $148.77 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40.This was the stock's third consecutive day of gains.Gilead Sciences Inc. closed 5.42% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.53% to $273.14, Pfizer Inc.  rose 2.15% to $28.57, and Abbott Laboratories  fell 0.46% to $116.13.Trading volume  remained 2.7 million below its 50-day average volume of 7.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","BK4550","BK4583","IE00B7SZLL34.SGD","LU0058720904.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","LU1023059063.AUD","LU2089984988.USD","LU0965509010.AUD","LU0965509101.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","BBH","LU2112291526.USD","LU1934455863.HKD","LU0965508806.USD","LU1061106388.HKD","BK4566","LU2468319806.SGD","SG9999015952.SGD","LU0882574055.USD","LU1674673691.USD","LU0861579265.USD","LU1037948541.HKD","LU2324357040.USD","LU1839511570.USD","LU0889565916.HKD","LU2087621335.USD","LU1066051498.USD","LU1778281490.HKD","BK4585","LU0114720955.EUR","MEDI","IE0002270589.USD","LU1934455194.USD","IE00B19Z3581.USD","TBXU","LU0823416689.USD","BK4532","IE00BKVL7J92.USD","LU1037948897.HKD","SG9999015945.SGD","LU0234570918.USD","GILD","IBBQ","LU0320765992.SGD","IE00B3T34201.USD","LU1934455277.USD","LU2357627491.SGD","LU1066053197.SGD","SG9999015986.USD","BK4139","BK4568","IBB","LU0122379950.USD","LU0289739699.SGD","LU0965509283.SGD","LU1674673428.USD","LU0109394709.USD","LU0859254822.USD","TMED","BK4588","IE00B19Z3B42.SGD","BK4578","BIB","LU1057294990.SGD","LU1571399168.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752593","title":"Moderna Inc. Stock Rallies 14.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752593?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:33","pubTimestamp":1787689980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. surged 14.4% to $158.83 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.7% to 26,151.30 and the Dow Jones Industrial Average rising 0.3% to 53,577.40.Moderna Inc. closed 10.1% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.5% to $273.14, Pfizer Inc. rose 2.1% to $28.57, and Gilead Sciences Inc. rose 1.38% to $148.77.Trading volume totaled 48.9 million, compared to the 50-day average of 15.2 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","LU0889565916.HKD","GILD","GNOM","IE00B3T34201.USD","IDNA","LU0965509101.SGD","BK4533","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","BK4588","IBB","LU0320765992.SGD","LU1057294990.SGD","LU1061106388.HKD","LGHT","LU0965509283.SGD","TBXU","LU0114720955.EUR","LU1037948541.HKD","BK4566","IE0002270589.USD","LU0823416689.USD","BK4568","WDNA","SG9999015978.USD","IE00B19Z3581.USD","LU0859254822.USD","BK4548","MRNX","LU1674673428.USD","SG9999015952.SGD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU0965509010.AUD","MEDI","MRNY","SG9999015986.USD","LU1430594728.SGD","BBH","LU1839511570.USD","BIB","IBBQ","TMED","MRNA","BK4534","BMED","BK4583","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662370257","title":"Political and General News Events from August 25","url":"https://stock-news.laohu8.com/highlight/detail?id=2662370257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662370257?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:25","pubTimestamp":1787664343,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 25Aug 25 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4N44M0UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","BK4566","LU2242646821.SGD","BK4581","LU0289739699.SGD","BK4585","IE00BJT1NW94.SGD","BK4533","PJP","AMGN","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU2468319806.SGD","BK4588","IE00BFTCPJ56.SGD","LU0122379950.USD","LU0868494617.USD","LU0320765992.SGD","LU2112291526.USD","IBB","IE00B2B36J28.USD","LU0889565916.HKD","BK4599","IBBQ","PBE","TBXU","LU1571399168.USD","SG9999001440.SGD","BK4534","LU0109394709.USD","BK4139","LU0058720904.USD","BIB","LU1983299246.USD","LU1057294990.SGD","LU1061106388.HKD","LU2242652126.USD","IE0009355771.USD","BBH","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662423737","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662423737","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662423737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:15","pubTimestamp":1787663703,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF  slightly advancing and the iShares Biotechnology ETF  up 0.2%.Immatics  shares were up more than 13% after the company said it has agreed to sell about 12.9 million ordinary shares at $8.69 each, and in lieu of ordinary shares to certain investors, pre-funded warrants to buy up to approximately 4.3 million ordinary shares at $8.689 per pre-funded warrant.Veeva Systems  has signed Biogen  and Regeneron Pharmaceuticals  as new users for its Veeva Vault CRM platform, according to statements from Veeva. Shares of Veeva Systems were down 0.1% premarket.Bausch + Lomb  stock was up more than 1% after the company said it plans to advance two of its pharmaceutical pipeline assets to new trials based on latest clinical results.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0114720955.EUR","LU0053666078.USD","LU0320765992.SGD","BK4581","BK4533","LU2468319806.SGD","BIIB","HCSG","XBI","LU1974910355.USD","BMED","LU2237438978.USD","LU0029874061.USD","LU2362541273.HKD","BK4504","VEEV","IMTX","IBBQ","BK4534","LABU","IBB","BK4588","LU0128526141.USD","IE00B19Z9P08.USD","LU0889565916.HKD","BLCO","LU0109394709.USD","BK4532","BBH","BK4198","LU0289739699.SGD","REGN","LU0058720904.USD","PBE","BK4528","LU2089984988.USD","IE00B894F039.SGD","LU0882574055.USD","LU2023250504.SGD","LU2362540622.SGD","BK4613","LU0823434740.USD","LU0234570918.USD","BK4139","LU1917777945.USD","LU0170899867.USD","TBXU","XLV","EKG","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662673234","title":"Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662673234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662673234?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:37","pubTimestamp":1787661420,"startTime":"0","endTime":"0","summary":"Underappreciated value stocks provide 'ballast' for investors, says Bank of AmericaEstée Lauder earns a rank among high-growth stocks beyond AI.In 2021 strategists at Bank of America's BofA Securities","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1057294990.SGD","IYH","IE00BDGV0183.EUR","IBKR","LU1064131342.USD","LU1868836757.USD","LU0353189763.USD","DXCM","LU0058720904.USD","LU2456880835.USD","SG9999001176.SGD","LU0390134368.USD","LU1791807156.HKD","IE00BFSS8Q28.SGD","LU0963586101.USD","HOYY","LU2462157665.USD","ABBV","XLF","LU1551013425.SGD","LU0965508806.USD","LU0211327993.USD","LU2111349929.HKD","BK4599","LU0912757837.SGD","IE0005OL40V9.USD","LU2237443549.SGD","LU1623119135.USD","FINX","FNCL","BK4211","HOII","VHT","IE00B1BXHZ80.USD","LU2129689514.USD","IE000F7OJYX1.SGD","BK4550","HUM","IE00BKPKM429.USD","VFH","LU1868837136.USD","LU0320765992.SGD","IYRI","LU2168564222.USD","SG9999015986.USD","LGLV","LU2461242641.AUD","REZ","LU0820561818.USD","LU1323610961.USD","SG9999014021.USD","LU0106831901.USD","LU1861558580.USD","LU0256863811.USD","LU2362540622.SGD","IE00B7KXQ091.USD","LU1839511570.USD","LU1917777945.USD","IE00B3PB1722.GBP","LU0158827948.USD","DPRE","LU1093756168.USD","LU0648000940.SGD","LLYX","C","LU2362541273.HKD","LU2552382058.USD","LU2210149790.SGD","LU0661504455.SGD","BK4225","LU0640476718.USD","LU0985320562.USD","LU2360106947.USD","LU0256863902.USD","FREL","LU0122379950.USD","LU0210536198.USD","LU0133085943.USD","LU2471134523.USD","LU0345770308.USD","HAUS","LU2417539215.USD","IE00BKDWB100.SGD","IE0001KFT4U8.USD","LU0690374615.EUR","LU1732800096.USD","IE00B2B36J28.USD","LU2552382215.SGD","BK4547","ILDR","HOOI","LU1720051017.SGD","LU0417517546.SGD","LU2357305700.SGD","LU2237957811.SGD","PJP","BK4533","LU0130517989.USD","GPZ","LU1880398471.USD","LU1883839398.USD","TRUH","BK4154","LU1291159041.SGD","SGXZ57979304.SGD","LU1935042215.USD","RITA","LU0964807845.USD","SGXZ81514606.USD","LU1162221912.USD","LU1267930490.SGD","SG9999018857.SGD","MEDX","LU1814569148.SGD","LU1035775433.USD","LU1629891620.HKD","BK4534","LU1668664300.SGD","RNTY","LU0310799852.SGD","CNC","LU0511384066.AUD","BK4528","SG9999014880.SGD","EKG","LU2129689431.USD","LU2023250504.SGD","IE0002270589.USD","LU1979441026.SGD","LU1023059063.AUD","LU2168563687.JPY","CURE","ELIL","IE00BVYPNV92.GBP","IE000WAW04H5.SGD","BK4558","LU1989771016.USD","SG9999017495.SGD","LU0316494557.USD","BK4207","LU1935042488.USD","LU1585245621.USD","SG9999018865.SGD","DFGR","LU0289739343.SGD","LU0320765059.SGD","LU1037948897.HKD","LU0943347566.SGD","LU0868494617.USD","LU0545039389.USD","LU0795875169.SGD","LU0787776722.HKD","XLRE","LU1127390331.HKD","SG9999014906.USD","PSR","LBO","LU0109394709.USD","SG9999011175.SGD","LU2106854487.HKD","LU2125909247.SGD","LU0289739699.SGD","IE00BLSP4452.SGD","LU2746668974.SGD","LU0477156953.USD","TMED","HRTS","LU2491050071.SGD","LU2433249047.HKD","LU0149725797.USD","SG9999014914.USD","LU2471134879.HKD","LU0124676726.USD","BK4135","LLY","LU0225283273.USD","LU0456855351.SGD","LU2213496289.HKD","LU0471298777.SGD","LU0321505868.SGD","LU0306807586.USD","LU1074936037.SGD","LU2237438978.USD","LU2108987350.USD","BK4127","HEAL","HOOW","LU2237957902.USD","IE0009355771.USD","LU0098860793.USD","HOOY","LU0070302665.USD","LU1244550494.USD","KKR","PODD","REIT","WELL","LU2065170008.USD","IE00BJT1NW94.SGD","LU1145028129.USD","IE00BSNM7G36.USD","LU1280957306.USD","LU1983299246.USD","LU0528227936.USD","LU2237443895.HKD","LU0689626769.HKD","LU1894683348.USD","LU0965509101.SGD","LU0471298694.HKD","LU2063271972.USD","HOOZ","SG9999001440.SGD","SG9999015952.SGD","LU0882574055.USD","FHLC","LU0861579265.USD","SGXZ31699556.SGD","LU0395794307.EUR","LU0238689110.USD","IYG","LU0823434740.USD","IE00BBT3K403.USD","IE00BMPRXN33.USD","XLV","LU2265009873.SGD","LU2361044865.SGD","LU2756315664.SGD","BK4566","IE00BN29S564.USD","LU2264538146.SGD","LU2746668461.USD","SG9999013999.USD","LLYZ","LU2087625088.SGD","SG9999014005.SGD","IE000BZT7R73.USD","LU0385154629.USD","LU0466842654.USD","LU2404859667.USD","TBXU","URE","LU0289961442.SGD","LU2168564149.EUR","LU1934455277.USD","LU2404859741.USD","MHIP","LU0868494708.USD","EL","CRPT","IAI","IE00BHPRN162.USD","IE0004445015.USD","LU1201861165.SGD","SG9999015978.USD","LU1934455194.USD","LU1363072403.SGD","CFG","LU2023251221.USD","LU2089283258.USD","BK4548","LU0689472784.USD","RWO","LU1267930730.SGD","AVRE","LU0823434583.USD","LU1003077747.HKD","LU1236620750.USD","KBWB","LU0158827781.USD","LU0965509283.SGD","BYRE","LU0203201768.USD","HOOG","LU1366192091.USD","LU1935042991.SGD","LU0859254822.USD","IHF","LU0052756011.USD","LU1069344957.HKD","LU1232071149.USD","LU2237443382.USD","IE0034235188.USD","IE0000B7K699.USD","LU0306806265.USD","LU2361044949.HKD","LU0130102774.USD","LU0211331839.USD","LU0174119429.USD","LU1989772840.SGD","BBH","LU1496350171.SGD","HOOC","LU1267930573.SGD","LU0203202063.USD","BK4504","FRI","LU2065171311.SGD","LU2602419157.SGD","LU0130103400.USD","WDNA","GLAM","LU1244550577.SGD","SG9999014898.SGD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU1236620834.HKD","PSP","LU0128525929.USD","LU1880398554.USD","REET","BK4598","BK4581","LU2211815571.USD","BK4585","BK4516","IE000MB6IJN5.SGD","LLII","BK4588","SG9999015945.SGD","LU0094547139.USD","LU1974910355.USD","LU2133065610.SGD","LU0949170772.SGD","LU0072461881.USD","IE00BK4W5L77.USD","LU1430594728.SGD","LU0198837287.USD","HOOD","JDOC","LU1084165304.USD","IQRA","LU1496350502.SGD","LU2750360997.AUD","IE00BJJMRY28.SGD","LU2125909593.SGD","LU1712237335.SGD","LU0234570918.USD","LU0310800965.SGD","IBB","LU2896262040.SGD","LU2023250330.USD","LU2471134952.CNY","ELIS","LU0079474960.USD","SPRE","LU0965509010.AUD","LU1929549753.HKD","SG9999001176.USD","IE00BN8TJ469.HKD","ERET","LU0128525689.USD","LU0310800379.SGD","LU2087621335.USD","LU0726765562.USD","LU2360032135.SGD","CANC","IE00BFXG1179.USD","HOOX","IE00B1XK9C88.USD","IE00B3QW5Z07.USD","IE00B4R5TH58.HKD","LU0348723411.USD","LU1868837300.USD","BK4007","LU0175139822.USD","CLIM","LU1037948541.HKD","LU0320765489.SGD","LU1244550221.USD","LU0820561909.HKD","IE0004445239.USD","SG9999003800.SGD","LU0345770993.USD","FTXO","LU0708995401.HKD","LU0211328371.USD","LU0029864427.USD","IAT","LU0320765646.SGD","LU0097036916.USD","LU1983260115.SGD","IXJ","RWR","LU0690374961.EUR","LU0323591593.USD","LU2756315318.SGD","IE000SO60NU8.SGD","RSPR","TFNS","BK4139","LU0553294199.USD","HODU","THNR","LU1894683264.USD","LU2129689605.HKD","LU1720051108.HKD","IE00B19Z3581.USD","IE00BFSS7M15.SGD","MEDI","LU2095319765.USD","IE00BGHQF631.EUR","GQRE","IE00BLSP4239.USD","LU1267930227.SGD","LU0170899867.USD","BLCK","LU0203347892.USD","IE00B4JS1V06.HKD","LU2357627491.SGD","IE00B7SZLL34.SGD","LU1093756325.SGD","LU1923622614.USD","LU1804176565.USD","IE00BK4W5M84.HKD","IE00BMPRXR70.SGD","SGXZ51526630.SGD","LU1791710400.SGD","LU0889565916.HKD","LU2168564495.EUR","LU1935043023.USD","LU2462591350.SGD","AGNG","LU2362541513.USD","LU1699723380.USD","LU0069063385.USD","LU0672654240.SGD","BBRE","SCHH","LU1061106388.HKD","LU2468319806.SGD","BK4551","BK4106","BK4203","LU1261432733.SGD","LU2552382132.HKD","BK4503","LU2211817866.USD","LU0162691827.USD","ICF","LU1868836914.USD","IE00B775H168.HKD","LU0208291251.USD","LU1035773651.USD","LU1691799644.USD","LU2596442595.SGD","BPAY","VGSR","LU0053666078.USD","LU0354030511.USD","LU0728928796.USD","LU2271345857.HKD","LU0648001328.SGD","LU0114720955.EUR","LU0321505439.SGD","LU2237443465.HKD","LU1551013342.USD","LU1861559042.SGD","IE00BVYPNW00.USD","LU0234572021.USD","GDOC","IE00B42XCP33.USD","IBBQ","LU1670627923.USD","LU2237443978.SGD","BK4227","LU1201861249.SGD","LU2210150020.SGD","LU0708994859.HKD","LU0289960550.SGD","USRT","IE00BJLML261.HKD","LU0203345920.USD","BK4559","JPRE","LU2324357040.USD","LU2347655073.USD","SGXZ99366536.SGD","REGN","LU2065169927.USD","LU0795875086.SGD","RXL","LU0823416689.USD","AAUM","LU2168564065.EUR","LU0109391861.USD","LU1670628061.USD","LU0820562030.AUD","LU0432979614.USD","LU2750360641.GBP","BK4082","LU2125154935.USD","BK4554","LU1718418525.SGD","LU2125154778.USD","LU2089284900.SGD","LU2089984988.USD","LU0096364046.USD","LU1732799900.SGD","LU0106261372.USD","LU1935043536.SGD","LU1144417596.USD","ROBN","LU2361045086.USD","LU0266013472.USD","LU0057025933.USD","BK4553","LU1868836591.USD","OZEM","LU1069347547.HKD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU1988902786.USD","DFAR","LU2112291526.USD","TRUR","LU0314106906.USD","ARES","CNCG","LU0006306889.USD","LU0683600562.USD","LU1506573853.SGD","UYG","IYF","BK4539","LU1548497426.USD","LU2471134796.USD","LU1989772923.USD","IE00BJJMRX11.SGD","IHE","IE00BKVL7J92.USD","LU2491050154.USD","PRVT","LU1934455863.HKD","FXH","LU0472753341.HKD","JRE","VNQ","SG9999014013.SGD","LU0882574139.USD","LU2347655156.SGD","LU2236285917.USD","PPH","LU0314104364.USD","BAC","IE0002141913.USD","LU0971096721.USD","FTXH","LU0477156797.USD","LU0786609619.USD","BK4183","IYR","IE00B19Z3B42.SGD","LU2491049909.HKD","LU0130518102.USD","LU0942090050.USD","GB00BDT5M118.USD","LU0354030438.USD","LU1119994496.HKD","IE00BWXC8680.SGD","LU0980610538.SGD","REIX","IE00BZ1G4Q59.USD","LU0353189680.USD","LU2028103732.USD","LU0738911758.USD","LU2237443622.USD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731506","title":"Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731506","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662731506?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:41","pubTimestamp":1787658092,"startTime":"0","endTime":"0","summary":"Veeva Systems  has signed Biogen  and Regeneron Pharmaceuticals  as new users for its Veeva Vault CRM platform, according to Tuesday statements from Veeva.No financial details were disclosed.Biogen will use Veeva Vault CRM as its agentic commercial foundation to deliver drugs to patients, while Regeneron plans to use the platform to generate commercial evidence that will back treatment adoption, Veeva said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","IE00B894F039.SGD","LU0109394709.USD","LU2089984988.USD","LU1974910355.USD","LU0266013472.USD","BK4139","LU1917777945.USD","BMED","PBE","IE00B19Z9P08.USD","LU0170899867.USD","LU1989764664.SGD","LU2362541273.HKD","BK4613","BK4585","LU0823434740.USD","LU1989764748.USD","LU2023250504.SGD","LU0234570918.USD","LU0320765992.SGD","BK4532","LU2362540622.SGD","BK4504","LU0882574055.USD","LU2237438978.USD","LU2106854487.HKD","LU0889565916.HKD","BK4588","LU0053666078.USD","BK4528","LU0289739699.SGD","REGN","IBBQ","BK4534","EKG","IBB","LGHT","LU0058720904.USD","LU0823434583.USD","LU0823416689.USD","LU2362541513.USD","BBH","LU2468319806.SGD","BK4167","BIIB","LU0114720955.EUR","BK4533","IE00B19Z9Z06.USD","VEEV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}